# OnKure (OKUR) — Analyst Forecast

OKUR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/okur/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 4 | 1 | 0 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 14, 2026 | Oppenheimer | Maintained | Outperform | $14.00 |
| Jul 20, 2026 | HC Wainwright & Co. | Maintained | Buy | $21.00 |
| Mar 16, 2026 | HC Wainwright & Co. | Maintained | Buy | $27.00 |
| Aug 26, 2025 | HC Wainwright & Co. | Maintained | Buy | $34.00 |
| Mar 18, 2025 | HC Wainwright & Co. | Maintained | Buy | $34.00 |
| Mar 11, 2025 | Oppenheimer | Maintained | Outperform | $30.00 |
| Jan 28, 2025 | Jones Trading | Initiated Coverage | Buy | $32.00 |
| Dec 5, 2024 | Leerink Partners | Initiated Coverage | Outperform | $33.00 |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | $40.00 |
| Oct 17, 2024 | HC Wainwright & Co. | Initiated Coverage | Buy | $40.00 |
| Oct 10, 2024 | Oppenheimer | Initiated Coverage | Outperform | $35.00 |
| May 14, 2024 | HC Wainwright & Co. | Maintained | Neutral | $1.50 |
| Dec 15, 2023 | Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 |
| Dec 15, 2023 | Jefferies | Downgraded | Buy → Hold | $1.80 |
| Dec 15, 2023 | HC Wainwright & Co. | Downgraded | Buy → Neutral | $1.50 |
| Nov 15, 2023 | William Blair | Initiated Coverage | Outperform | — |
| Nov 14, 2023 | HC Wainwright & Co. | Maintained | Buy | $30.00 |
| Oct 12, 2023 | HC Wainwright & Co. | Maintained | Buy | $30.00 |
| Sep 8, 2023 | HC Wainwright & Co. | Maintained | Buy | $30.00 |
| Aug 28, 2023 | HC Wainwright & Co. | Initiated Coverage | Buy | $30.00 |

## Frequently Asked Questions

### Is OKUR a buy, sell, or hold?

Analysts covering OnKure currently average a Buy rating: 4 buy, 1 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on OKUR?

On Aug 14, 2026, Oppenheimer maintained OnKure at Outperform with a price target of $14.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).